Molecular biology reports · 2025
Combined effects of 5-azacytidine and oleuropein on miR-149-3p, miR-375, miR-574-5p expression and apoptosis in acute myeloid leukemia (AML) cell lines HL-60 and THP-1.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kelaye Shohre Karimi, Kazemi Bahareh, Najafi Fatemeh, Foruzandeh Zahra, Solali Saeed
Аннотация
BACKGROUND: Acute myeloid leukemia (AML) is an aggressive hematological malignancy characterized by the rapid proliferation of immature myeloid cells and poor clinical outcomes. Despite conventional treatments such as chemotherapy and hematopoietic stem cell transplantation, relapse and resistance remain major challenges. Epigenetic alterations-particularly dysregulated DNA methylation and microRNA (miRNA) expression- are crucial in AML pathogenesis.
OBJECTIVE: This study aimed to investigate the synergistic effects of azacitidine, a DNA methyltransferase inhibitor, and oleuropein, a natural polyphenol with anticancer properties, on AML cell lines (THP-1 and HL-60).
METHODS: AML cells were treated with azacitidine, oleuropein, or their combination. Cell proliferation was evaluated using MTT assays, apoptosis was assessed via flow cytometry (Annexin V-FITC/PI staining), and miRNA expression levels were quantified using real-time PCR.
RESULTS: Both azacitidine and oleuropein reduced cell viability and induced apoptosis in a dose- and time-dependent manner. The combination treatment significantly enhanced apoptosis, resulting in a 2.5-fold increase in Annexin V-positive HL-60 cells at 72 h. Additionally, the treatment modulated miRNA expression, upregulating miR-149-3p and miR-375, while downregulating miR-574-5p.
CONCLUSION: The synergistic effects of oleuropein and azacitidine suggest a promising therapeutic strategy for AML by targeting epigenetic mechanisms and miRNA pathways. Further in vivo studies and clinical trials are warranted to validate these findings and optimize treatment protocols.
OBJECTIVE: This study aimed to investigate the synergistic effects of azacitidine, a DNA methyltransferase inhibitor, and oleuropein, a natural polyphenol with anticancer properties, on AML cell lines (THP-1 and HL-60).
METHODS: AML cells were treated with azacitidine, oleuropein, or their combination. Cell proliferation was evaluated using MTT assays, apoptosis was assessed via flow cytometry (Annexin V-FITC/PI staining), and miRNA expression levels were quantified using real-time PCR.
RESULTS: Both azacitidine and oleuropein reduced cell viability and induced apoptosis in a dose- and time-dependent manner. The combination treatment significantly enhanced apoptosis, resulting in a 2.5-fold increase in Annexin V-positive HL-60 cells at 72 h. Additionally, the treatment modulated miRNA expression, upregulating miR-149-3p and miR-375, while downregulating miR-574-5p.
CONCLUSION: The synergistic effects of oleuropein and azacitidine suggest a promising therapeutic strategy for AML by targeting epigenetic mechanisms and miRNA pathways. Further in vivo studies and clinical trials are warranted to validate these findings and optimize treatment protocols.